Predicting antimicrobial resistance prevalence and incidence from indicators of antimicrobial use: What is the most accurate indicator for surveillance in intensive care units?

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Fortin, Élise ^a,b   Platt, Robert W ^a   Fontela, Patricia S ^a,c   Buckeridge, David L ^a   Quach, Caroline ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANTIBIOTIC RESISTANCE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; NONHUMAN; PREDICTION; PREVALENCE; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; CLINICAL TRIAL; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGICAL MONITORING; MULTICENTER STUDY; NEONATAL INTENSIVE CARE UNIT; PSEUDOMONAS; PSEUDOMONAS INFECTIONS;

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ANTI-BACTERIAL AGENTS; CARBAPENEMS; COHORT STUDIES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGICAL MONITORING; HUMANS; INTENSIVE CARE UNITS, NEONATAL; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES;

EID: 84957547776     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145088     Document Type: Article

References (32)

1. Schechner V, Temkin E, Harbarth S, Carmeli Y, Schwaber MJ. Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev. 2013; 26:289-307. doi: 10.1128/CMR.00001-13 PMID: 23554418
2. Steinke D, Davey P. Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies. Clin Infect Dis. 2001; 33 Suppl 3:S193-205. PMID: 11524719
3. Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis. 2001; 32:1044-54. PMID: 11264033
4. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. The Lancet. 2005; 365:579-87.
5. World Health Organization. Anti-Infective Drug Resistance Surveillance and Containment Team. WHO global strategy for containment of antimicrobial resistance. Geneva: World Health Organization; 2001. 99 p. p.
6. NHSN. Antimicrobial Use and Resistance (AUR) Module. 2014. Available from: http://www.cdc.gov/nhsn/PDFs/pscManual/11pscAURcurrent.pdf.
7. Dellit TH, Owens RC, McGowan JE Jr., Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44:159-77. PMID: 17173212
8. Transatlantic Taskforce on Antimicrobial Resistance. Transatlantic Taskforce on Antimicrobial Resistance Progress Report - Recommendations for future collaboration between the US and EU. 2014. 85 p.]. Available from: http://www.cdc.gov/drugresistance/pdf/TATFAR-Progress-report-2014.pdf.
9. WHO Collaborating Centre for Drug Statistics Methodology; Norwegian Institute of Public Health. Guidelines for ATC classification and DDD assignment. 4th ed. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2011. 286 p. p.
10. Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, et al. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother. 2011; 66:443-9. doi: 10.1093/jac/dkq430 PMID: 21084362
11. Fortin E, Fontela PS, Manges AR, Platt RW, Buckeridge DL, Quach C. Measuring antimicrobial use in hospitalized patients: a systematic review of available measures applicable to paediatrics. J Antimicrob Chemother. 2014; 69:1447-56. doi: 10.1093/jac/dku003 PMID: 24481320
12. Haug JB, Reikvam A. WHO defined daily doses versus hospital-adjusted defined daily doses: impact on results of antibiotic use surveillance. J Antimicrob Chemother. 2013; 68:2940-7. doi: 10.1093/jac/dkt268 PMID: 23838948
13. Ruef C. What's the best way to measure antibiotic use in hospitals? Infection. 2006; 34:53-4. PMID: 16703292
14. de With K, Maier L, Steib-Bauert M, Kern P, Kern WV. Trends in antibiotic use at a university hospital: defined or prescribed daily doses? Patient days or admissions as denominator? Infection. 2006; 34:91-4. PMID: 16703299
15. Ibrahim OM, Polk RE. Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti Infect Ther. 2012; 10:445-57. doi: 10.1586/eri.12.18 PMID: 22512754
16. Monnet DL. Measuring antimicrobial use: the way forward. Clin Infect Dis. 2007; 44:671-3. PMID: 17278057
17. Berrington A. Antimicrobial prescribing in hospitals: be careful what you measure. J Antimicrob Chemother. 2010; 65:163-8. doi: 10.1093/jac/dkp399 PMID: 19884120
18. Filius PM, Liem TB, van der Linden PD, Janknegt R, Natsch S, Vulto AG, et al. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother. 2005; 55:805-8. PMID: 15814603
19. Fortin E, Gonzales M, Fontela PS, Platt RW, Buckeridge DL, Quach C. Improving quality of data extractions for the computation of patient-days and admissions. Am J Infect Control. 2015; 43:174-6. doi: 10.1016/j.ajic.2014.10.024 PMID: 25530553
20. Cohen AL, Calfee D, Fridkin SK, Huang SS, Jernigan JA, Lautenbach E, et al. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper. Infect Control Hosp Epidemiol. 2008; 29:901-13. doi: 10.1086/591741 PMID: 18808340
21. WHO Collaborating Centre for Drug Statistics Methodology; Norwegian Institute of Public Health. ATC/DDD Index 2014. 2014. Available from: http://www.whocc.no/atc-ddd-index/.
22. Gilbert DN, Robert C. Moellering JMD, Eliopoulos GM, Sande MA, Chamber HF. The Sanford Guide to Antimicrobial Therapy: Antimicrobial Therapy; 2008.
23. La Salle M, Moore D, Quach C, McDonald J, Rubin E, Noya F. Montreal Children's Hospital Pediatric Drug Formulary - Antimicrobial Agents. Moore D, editor. Montreal2004.
24. Pickering LK, Long SS. Red Book: 2012 Report of the Committee on Infectious Diseases: American Academy of Pediatrics; 2012. 1058 p. p.
25. Bradley J, Nelson JD, Kimberlin DW, Leake JAD, Palumbo PE, Sanchez PJ, Sauberan J, Steinbach WJ. 2012-2013 Nelson's Pediatric Antimicrobial Therapy, 19th Edition: American Academy of Pediatrics; 2012.
26. Maldonado G, Greenland S. A comparison of the performance of model-based confidence intervals when the correct model form is unknown: coverage of asymptotic means. Epidemiology. 1994; 5:171-82. PMID: 8172992
27. Hyndman RJ. Another look at forecast-accuracy metrics for intermittent demand. Foresight. 2006; 8:43-6.
28. Holm S. A Simple Sequentially Rejective Multiple Test Procedure. Scandinavian Journal of Statistics. 1979; 6:65-70.
29. Gilca R, Hubert B, Fortin E, Gaulin C, Dionne M. Epidemiological patterns and hospital characteristics associated with increased incidence of Clostridium difficile infection in Quebec, Canada, 1998-2006. Infect Control Hosp Epidemiol. 2010; 31:939-47. doi: 10.1086/655463 PMID: 20677973
30. Li H, Luo YF, Williams BJ, Blackwell TS, Xie CM. Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies. Int J Med Microbiol. 2012; 302:63-8. doi: 10.1016/j.ijmm.2011.10.001 PMID: 22226846
31. Kern WV, de With K, Steib-Bauert M, Fellhauer M, Plangger A, Probst W. Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001-2002. Infection. 2005; 33:333-9. PMID: 16258863
32. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007; 44:664-70. PMID: 17278056